Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer;Étude de faisabilité (Phase I-II) d'une quadruple combinaison associant le 5-fluorouracile, l'acide folinique et le carboplatine à de l'irinotecan administrés en infusion chronomodulée pour le traitement du cancer colorectal avancé

Pathologie Biologie

Volumn 53, Issue 5, 2005, Pages 277-280

  Focan, C ^a   Kreutz, F ^a   Graas, M P ^a   Longree L ^a   Moeneclaey, N ^a   David, A ^a   Focan Henrard, D ^a  

^a Clinique Saint Joseph   (Belgium)

Author keywords

Ambulatory medicine; Chronotherapy; Colorectal cancer; Combination chemotherapy; Irinotecan

Indexed keywords

CARBOPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CHRONOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG INFUSION; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SKIN MANIFESTATION; TREATMENT OUTCOME; VOMITING; CHRONOBIOLOGY; COHORT ANALYSIS; COLORECTAL TUMOR; DOSE RESPONSE; DRUG ADMINISTRATION; FEASIBILITY STUDY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARBOPLATIN; CHRONOBIOLOGY; COHORT STUDIES; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED;

EID: 20444401941     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.12.027     Document Type: Article

References (9)

1. C. Focan, F. Kreutz, D. Focan-Henrard, and N. Moeneclaey Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial Eur. J. Cancer 36 2000 341 347
2. C. Focan, F. Kreutz, and L. Longŕe Chronoth́rapie associant le 5-fluorouracile, l'acide folinique, et le carboplatine en premìre ligne th́rapeutique dans le cancer colorectal ḿtastatique. Une ́tude de phase II Pathol. Biol. 2005 (in press)
3. D. Cunningham, S. Pyrhonen, and R.D. James Randomised trial of irinotecan plus supportive care vs supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer Lancet 352 1998 1413 1418
4. S. Giacchetti, B. Perpoint, and R. Zidani Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Classic Papers and Current Comments J. Clin. Oncol. 6 2002 885 897
5. L.B. Saltz, J.V. Cox, and C. Blancke Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N. Engl. J. Med. 343 2000 905 914
6. C. Tournigand, T. Andŕ, and E. Achille Folfiri followed by Folfox 6 or the reverse sequence in advanced colorectal cancer: a randomized Gercor study J. Clin. Oncol. 22 2004 229 237
7. T.G. Granda, R.M. D'Attino, and E. Filipski Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma Br. J. Cancer 86 6 2002 999 1005
8. S. Giacchetti, H. Cuŕ, and A. Adenis Randomized multicenter trial of irinotecan (CPT) chronomodulated (Chrono) versus Standard (Std) infusion in patients (Pts) with metastatic colorectal cancer (MCC) Proc. of ASCO 20 2001 117b
9. C. Garufi, E. Bria, and B. Vanni A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients Br. J. Cancer 89 10 2003 1870 1875